Bevacizumab Health Dictionary

Bevacizumab: From 1 Different Sources


n. a *monoclonal antibody that interferes with the growth of new blood vessels (see angiogenesis) by inhibiting the action of *vascular endothelial growth factor. It is licensed for the treatment of metastatic colorectal cancer, breast cancer, ovarian cancer, cervical cancer, and non-small-cell lung cancer. Side-effects include hypertension, bowel perforation, and bleeding; there may be a risk of osteonecrosis of the jaw.
Health Source: Oxford | Concise Colour Medical Dictionary
Author: Jonathan Law, Elizabeth Martin

Angiogenesis Inhibitor

an agent that prevents the development of new blood vessels (*angiogenesis) by inhibiting the action of *vascular endothelial growth factor (it is also known as anti-VEGF). Angiogenesis inhibitors are used as anticancer drugs, since growing cancers have a greater need for blood supply than normal tissue and must develop new blood vessels before progressing beyond a very small size. They include *aflibercept, *bevacizumab, and *thalidomide. Because of their action, some of these drugs are used in the treatment of wet age-related *macular degeneration.... angiogenesis inhibitor

Avastin

n. see bevacizumab.... avastin

Cytotoxic Drug

any drug that damages or destroys cells: usually refers to those drugs used to treat various types of cancer. There are various classes of cytotoxic drugs, including *alkylating agents (e.g. *chlorambucil, *cyclophosphamide, *melphalan), *antimetabolites (e.g. *fluorouracil, *methotrexate, *mercaptopurine), *anthracycline antibiotics (e.g. *doxorubicin, *daunorubicin, *dactinomycin), *vinca alkaloids, and platinum compounds (e.g. *carboplatin, *cisplatin). Other cytotoxic drugs include *taxanes and *topoisomerase inhibitors, and some *monoclonal antibodies (e.g. *bevacizumab, *trastuzumab) have cytotoxic activity. All these drugs offer successful treatment in some conditions and help reduce symptoms and prolong life in others. Cytotoxic drugs destroy cancer cells by interfering with cell division, but they also affect normal cells, particularly in bone marrow (causing *myelosuppression), hair follicles (causing hair loss), the stomach lining (resulting in severe nausea and vomiting), mouth (causing soreness), and fetal tissue (they should not be taken during the later stages of pregnancy). Dosage must therefore be carefully controlled. See also chemotherapy.... cytotoxic drug

Targeted Agent

(targeted therapy) a drug that interferes with specific molecular targets in the pathways involved in cancer cell growth and signalling, in contrast to *cytotoxic drugs that act primarily on rapidly dividing cells. It typically requires prolonged courses of treatment, and the anticancer action can be synergistic with *chemotherapy. Many new drugs are being developed and are undergoing trials to determine optimal use. The *tyrosine kinase inhibitors include imatinib and *epidermal growth factor receptor inhibitors; multitargeted agents include *sorafenib and *sunitinib. The monoclonal antibodies include *rituximab, *trastuzumab, *cetuximab, and *bevacizumab.... targeted agent

Vascular Endothelial Growth Factor

(VEGF) a *growth factor made by both normal cells and their abnormal or malignant counterparts to stimulate new blood vessel formation (see angiogenesis). It can be targeted by a family of drugs known as *angiogenesis inhibitors, which include *bevacizumab.... vascular endothelial growth factor



Recent Searches